Amyloid-beta
4 stories
-
healthMajor Cochrane Review Questions Effectiveness of Alzheimer's Drugs
A Cochrane review finds amyloid-targeting drugs offer little benefit, sparking debate among experts and drugmakers.
-
healthWeight-Loss Drugs Show Potential in Reducing Alzheimer's Protein Buildup
A major review suggests popular GLP-1 weight-loss drugs may help limit the molecular hallmarks of Alzheimer's disease, reducing amyloid-beta and tau proteins in preclinical studies.
-
healthScientists Identify Brain's 'Molecular Switch' Protecting Against Alzheimer's Decline
New research reveals a protein, chromogranin A, may be key to cognitive resilience in Alzheimer's, offering potential therapeutic targets.
-
healthNew Blood Test Shows Promise for Early Alzheimer's Prediction
Groundbreaking research indicates a blood biomarker, pTau217, could identify Alzheimer's risk years before symptoms manifest, potentially revolutionizing early detection and intervention.